)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals (ZNTL) investor relations material
Zentalis Pharmaceuticals Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary25 Feb, 2026
Strategic focus and clinical development
Leadership joined in fall 2024, attracted by robust clinical data for azenosertib as a first oral non-chemo option for biomarker-selected PROC patients.
Over 500 patients have been treated with azenosertib, showing response rates above 30% and around six months duration of response, outperforming standard chemo.
Two pivotal studies are underway: DENALI (for accelerated approval) and ASPENOVA (phase III confirmatory trial for full approval).
DENALI is enrolling, aiming for 100 patients at the selected dose with a readout by year-end; ASPENOVA will support full approval.
Regulatory alignment with the FDA has been established for both accelerated and full approval pathways.
Differentiation and competitive landscape
Azenosertib offers a non-chemo, oral alternative, addressing quality-of-life and convenience for patients who otherwise face frequent IV infusions.
ADCs are seen as complementary rather than competitive, with potential for combination regimens.
The oral regimen is particularly valuable for older patients and those distant from cancer centers.
Quality of life and convenience are emphasized as key differentiators.
Trial design, biomarker strategy, and regulatory process
DENALI includes a two-dose randomized portion; dose selection will be confirmed with the FDA before public disclosure.
Both 300mg and 400mg doses show similar safety, with higher efficacy expected at 400mg based on prior data.
Cyclin E1 protein overexpression, not just gene amplification, is used as the biomarker to maximize patient benefit.
Biomarker cutoffs are validated across multiple retrospective and prospective studies, with ongoing prospective validation in DENALI.
ASPENOVA mirrors the MIRASOL trial design but selects for Cyclin E1 positive patients, who have a poorer prognosis.
Why is accelerated approval still viable vs ADCs?
How will DENALI Part 2 improve ORR/DOR?
How does CCNE1 selection impact ASPENOVA control?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Zentalis Pharmaceuticals earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
Zentalis Pharmaceuticals
Next Zentalis Pharmaceuticals earnings date
TD Cowen 46th Annual Health Care Conference3 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Zentalis Pharmaceuticals Inc., operating under the ticker ZNTL on the NASDAQ, is a clinical-stage biopharmaceutical company with a dedicated focus on the discovery and development of small molecule therapeutics aimed at various cancer types. Its pipeline includes a variety of compounds in different stages of clinical trials, targeting key biological pathways in cancer. Zentalis Pharmaceuticals is headquartered in NYC and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage